Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Newlyinvented Ai Model

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Recruiting1
Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06616506Recruiting

Artificial Intelligence for Highly Myopic Cataract

NCT05538793Completed

Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study

NCT03550625Unknown

Computer Assisted Selection of Serrated Adenomas and Neoplastic Polyps - a New Clinical DRAft

Showing all 3 trials

Research Network

Common Treatments

  • Newlyinvented Ai Model1
  • Computer Program1

Active Sponsors

  • Technical University of Munich1
  • Eye & ENT Hospital of Fudan University1
  • Ningbo Eye Hospital1
  • Shanghai High Myopia Study Group1

Top Investigators

Related Conditions

  • Diagnoses Disease1
  • Risk Reduction1
  • Image1
  • Keratitis1
  • Myopia1

Activity Timeline